Navigation Links
Ensil Canada Announces First Successful Test and Validation of Vastusys Line of Products in Ontario Laboratories
Date:7/11/2013

MARKHAM, Ontario, July 11, 2013 /PRNewswire/ -- This morning Ensil Canada announced the exciting news that its scientific team of researchers and engineers have made a major breakthrough in the development of a revolutionary medical product that has the potential to help patients who suffer from mobility issues.

Ensil Canada has completed successful test results that show a proprietary communication device can be used to communicate with the brain and bypass the spine. This breakthrough meets the targets set by Ensil to have a prototype of a device by the end of 2013 for more comprehensive testing.

"We are very proud and confident that we have developed a product at our Ontario, Canada facilities that could help tens of thousands of people who suffer from mobility issues," said Farsad Kiani, CEO of Ensil Canada. "This is a phenomenal first step. It is our hope that we can bring this product to market, so that people can continue enjoying their day to day activities such as jogging, swimming and walking."

Today's announcement is one of the many areas of research by Ensil Canada to improve the lives of people across the world. Over the past three decades, Ensil Canada has made many positive breakthroughs and worked in the community to improve people's health and wellbeing. Recent work has included major advancements in the quality of the life of those whose their life has been affected by Stroke, Multiple Scoliosis, Spinal Cord injury or paralysis.

Ensil Canada focuses on enhancing mission critical technologies in the areas of Aerospace, Defence and Medical Diagnostic Equipment. Ensil's research and development divisions' mission is to develop new technologies or improve existing technologies through its own in-house research activities and resources.

Ensil Canada, a member of Ensil group of companies (www.ensil.ca), focuses on enhancing mission critical technologies in the areas of aerospace, defence, telecommunication and medical diagnostic equipment.

Ensil's R&D divisions' mission is to develop new technologies or improve existing technologies through in-house research activities.

For further information please contact us at: info @ensil.com or visit us at www.ensil.ca.

This press release was issued through 24-7PressRelease.com.  For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Ensil Canada Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
2. Canada-based Radimetrics Announces Expansion to Scotland
3. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
4. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
5. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
6. VirtualScopics Receives Issuance of Influential Patent in Canada
7. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
8. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
9. Sensus Healthcare Announces Health Canada Approval
10. New Treatment For Obstructive Sleep Apnea Now Available In Canada
11. Integrated Marketing Company Expands Into Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... ... ... – Monday, September 18 th .The Brain Tumor Foundation (BTF) begins ... the public.Where:  BTF,s Mobile MRI Unit – a ... Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early Detection Sponsor-A-City ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
(Date:9/7/2017)... MIRAGE, Calif. , Sept. 7, 2017  For nearly two decades, ... service in the Assisted Reproduction Insurance industry. Today, New Life Agency announces ... fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... Silicon Valley ... even on the go. Their electric toothbrushes aggressively attack oral bacteria by reducing ... sanitizing technology. Combining leading edge Enke technology with a premium timeless design, they ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Letters From Home”: a moving ... lost, have value to God. “Letters From Home” is the creation of published author, ... the President’s Cabinet of Jerry Savelle Ministries International, who has traveled and ministered on ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... and create life. Although frozen embryos have a slight statistical advantage for live ... freezing is a wonderful opportunity for women undergoing medical treatment or who are ...
(Date:9/21/2017)... ... 21, 2017 , ... With ProSlideshow Portrait from Pixel Film Studios creating a ... select from up to two layers of subject matter along with fully customizable backdrop ... Final Cut Pro X. , With ProSlideshow Portrait each user are given ...
(Date:9/21/2017)... ... 21, 2017 , ... Process Capability Indices for Medical Device ... ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing is ... Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning letter. ...
Breaking Medicine News(10 mins):